There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CureVac (CVAC – Research Report), MoonLake Immunotherapeutics (MLTX – Research Report) and Cara Therapeutics (CARA – Research Report) with bullish sentiments.
CureVac (CVAC)
JMP Securities analyst Roy Buchanan reiterated a Buy rating on CureVac today and set a price target of $18.00. The company’s shares closed last Tuesday at $5.54, close to its 52-week low of $4.95.
According to TipRanks.com, Buchanan has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $15.67.
See the top stocks recommended by analysts >>
MoonLake Immunotherapeutics (MLTX)
Needham analyst Serge Belanger maintained a Buy rating on MoonLake Immunotherapeutics today and set a price target of $66.00. The company’s shares closed last Tuesday at $36.95.
According to TipRanks.com, Belanger is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for MoonLake Immunotherapeutics with a $70.09 average price target, an 89.4% upside from current levels. In a report issued on November 1, Stifel Nicolaus also initiated coverage with a Buy rating on the stock with a $74.00 price target.
Cara Therapeutics (CARA)
H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Cara Therapeutics today and set a price target of $7.00. The company’s shares closed last Tuesday at $1.06, close to its 52-week low of $1.03.
According to TipRanks.com, Livnat is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cara Therapeutics with a $4.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CVAC:
